Research Presented at 14th International Symposium on Ginseng Highlights Red Ginseng’s Potential Benefits Against Age-Related Health Decline Clinical and preclinical research presented at the 14th International Symposium on Ginseng has highlighted the potential of Korean red ginseng (Panax ginseng C.A.…
City of Hope Honors Primary Wave Music CEO Larry Mestel With Spirit of Life Award for Cancer Philanthropy City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, has honored Larry…
Prilenia Therapeutics and Ferrer to Present New Pridopidine Data and PREVAiLS Trial Updates at NEALS 2026 Prilenia Therapeutics B.V. and Ferrer have announced plans to present new clinical data and updates on the ongoing PREVAiLS study at the Northeast Amyotrophic…
Arrowhead Pharmaceuticals’ REDEMPLO Gains NICE Recommendation for NHS Treatment of Familial Chylomicronaemia Syndrome in England and Wales Arrowhead Pharmaceuticals’ REDEMPLO® (plozasiran) has received a positive funding recommendation from the National Institute for Health and Care Excellence (NICE), creating a new…
Incyte Presents Updated Clinical Data for KRAS G12D and TGFβR2×PD-1 Programs in Pancreatic and Colorectal Cancers Incyte has announced new clinical findings from its expanding oncology portfolio, highlighting the potential of two investigational cancer therapies in difficult-to-treat pancreatic and colorectal…
Ionis and Roche Report Phase 3 Sefaxersen Data Showing Significant Proteinuria Reduction in IgA Nephropathy Ionis Pharmaceuticals, Inc. and its partner Roche have announced positive late-breaking results from the ongoing Phase 3 IMAgINATION study evaluating investigational sefaxersen in adults with…
Brenus Pharma Reports Promising Phase Ia Results for STC-1010 in Metastatic Colorectal Cancer, With 57% Objective Response Rate Brenus Pharma, a clinical-stage biotechnology company developing innovative immunotherapies for cancer, has announced the first clinical results from the Phase Ia dose-escalation…
Zai Lab Secures $250 Million PIPE Financing to Support Global Development of Zocilurtatug Pelitecan Zai Lab Limited, an innovation-driven global biopharmaceutical company, has entered into a securities purchase agreement to raise approximately $250 million through a private investment in public…
Nutromics Demonstrates World-First Real-Time Creatinine Monitoring in Humans Using DNA-Based Wearable Sensors Nutromics has presented what it describes as world-first real-time measurements of creatinine in humans using DNA-based sensors, marking a significant development in the potential application of wearable technology…
ViiV Healthcare Reports Five-Year Real-World Evidence Supporting Long-Term Cabenuva Effectiveness in HIV Treatment ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, has announced new real-world evidence from the OPERA observational cohort evaluating…
HeartBeam Completes Enrollment in 486-Patient HEADSTART-ACS Study Ahead of Schedule to Advance 3D ECG Heart Attack Detection Technology HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac insights, has announced the early completion…
Algia Pharma Completes IND-Enabling Toxicology Study for AlgiaPak, Advancing Non-Opioid Acute Pain Treatment Toward Clinical Trials Algia Pharma, LLC has announced the successful completion of an Investigational New Drug (IND)-enabling preclinical toxicology study for AlgiaPak®, a hospital-grade multimodal pain management…